MX2023004441A - Composiciones de relleno de liberacion controlada y capsulas que las contienen. - Google Patents
Composiciones de relleno de liberacion controlada y capsulas que las contienen.Info
- Publication number
- MX2023004441A MX2023004441A MX2023004441A MX2023004441A MX2023004441A MX 2023004441 A MX2023004441 A MX 2023004441A MX 2023004441 A MX2023004441 A MX 2023004441A MX 2023004441 A MX2023004441 A MX 2023004441A MX 2023004441 A MX2023004441 A MX 2023004441A
- Authority
- MX
- Mexico
- Prior art keywords
- controlled release
- release fill
- fill composition
- daltons
- soft
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063092679P | 2020-10-16 | 2020-10-16 | |
| PCT/US2021/054991 WO2022081848A1 (en) | 2020-10-16 | 2021-10-14 | Controlled release fill compositions and capsules containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023004441A true MX2023004441A (es) | 2023-05-08 |
Family
ID=81209315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023004441A MX2023004441A (es) | 2020-10-16 | 2021-10-14 | Composiciones de relleno de liberacion controlada y capsulas que las contienen. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230372252A1 (enExample) |
| EP (1) | EP4228608A4 (enExample) |
| JP (1) | JP2023545494A (enExample) |
| KR (1) | KR20230088730A (enExample) |
| CN (1) | CN116367864A (enExample) |
| AR (1) | AR123800A1 (enExample) |
| AU (2) | AU2021360905B2 (enExample) |
| CA (1) | CA3195386A1 (enExample) |
| CO (1) | CO2023005368A2 (enExample) |
| IL (1) | IL301692A (enExample) |
| MX (1) | MX2023004441A (enExample) |
| NZ (1) | NZ799086A (enExample) |
| TW (1) | TW202228655A (enExample) |
| WO (1) | WO2022081848A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240099982A1 (en) * | 2022-09-27 | 2024-03-28 | Gaia Herbs | Cellulose derivative free capsule for herbal extracts |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2627292C (en) * | 2005-10-26 | 2012-04-17 | Banner Pharmacaps, Inc. | Hydrophilic vehicle-based dual controlled release matrix system |
| US10960077B2 (en) * | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| PE20141171A1 (es) * | 2011-10-06 | 2014-09-21 | Gruenenthal Chemie | Forma de dosificacion farmaceutica oral resistente a alteracion comprendiendo agonista opioide y antagonista opioide |
| US20150366814A1 (en) * | 2014-06-23 | 2015-12-24 | Banner Life Sciences Llc | All-natural enteric soft capsules comprising active ingredients |
| WO2016140933A2 (en) * | 2015-03-02 | 2016-09-09 | Bionpharma Healthcare Llc | Immediate release soluble ibuprofen compositions |
| EP3285746A1 (en) * | 2015-04-24 | 2018-02-28 | Grünenthal GmbH | Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a powder |
| WO2016170097A1 (en) * | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant dosage form with immediate release and resistance against solvent extraction |
| US9943513B1 (en) * | 2015-10-07 | 2018-04-17 | Banner Life Sciences Llc | Opioid abuse deterrent dosage forms |
| EP3856160A4 (en) * | 2018-09-25 | 2022-07-06 | SpecGx LLC | ABUSE-PROOF IMMEDIATE RELEASE CAPSULE DOSAGE FORMS |
-
2021
- 2021-10-14 NZ NZ799086A patent/NZ799086A/en unknown
- 2021-10-14 KR KR1020237013939A patent/KR20230088730A/ko active Pending
- 2021-10-14 AU AU2021360905A patent/AU2021360905B2/en active Active
- 2021-10-14 CN CN202180070429.6A patent/CN116367864A/zh active Pending
- 2021-10-14 CA CA3195386A patent/CA3195386A1/en active Pending
- 2021-10-14 JP JP2023522950A patent/JP2023545494A/ja active Pending
- 2021-10-14 EP EP21881089.3A patent/EP4228608A4/en active Pending
- 2021-10-14 IL IL301692A patent/IL301692A/en unknown
- 2021-10-14 US US18/248,415 patent/US20230372252A1/en active Pending
- 2021-10-14 MX MX2023004441A patent/MX2023004441A/es unknown
- 2021-10-14 WO PCT/US2021/054991 patent/WO2022081848A1/en not_active Ceased
- 2021-10-15 AR ARP210102851A patent/AR123800A1/es unknown
- 2021-10-15 TW TW110138319A patent/TW202228655A/zh unknown
-
2023
- 2023-04-27 CO CONC2023/0005368A patent/CO2023005368A2/es unknown
-
2026
- 2026-03-05 AU AU2026201700A patent/AU2026201700A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2026201700A1 (en) | 2026-03-26 |
| EP4228608A1 (en) | 2023-08-23 |
| TW202228655A (zh) | 2022-08-01 |
| AU2021360905B2 (en) | 2026-01-08 |
| AU2021360905A1 (en) | 2023-06-01 |
| KR20230088730A (ko) | 2023-06-20 |
| JP2023545494A (ja) | 2023-10-30 |
| NZ799086A (en) | 2026-02-27 |
| AR123800A1 (es) | 2023-01-11 |
| WO2022081848A1 (en) | 2022-04-21 |
| CO2023005368A2 (es) | 2023-05-19 |
| CN116367864A (zh) | 2023-06-30 |
| CA3195386A1 (en) | 2022-04-21 |
| AU2021360905A9 (en) | 2024-10-10 |
| IL301692A (en) | 2023-05-01 |
| EP4228608A4 (en) | 2024-10-02 |
| US20230372252A1 (en) | 2023-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2226418T3 (es) | Composiciones para recubrimiento de almidon modificado. | |
| AU5901999A (en) | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture | |
| US6517865B2 (en) | Polymer film compositions for capsules | |
| US7045184B2 (en) | Polyvinyl alcohol compositions | |
| KR100634571B1 (ko) | 연질 젤라틴 제제용 약학 조성물의 제조 방법 | |
| TWI255722B (en) | Non-gelatin type encapsulating composition and capsule obtained therefrom | |
| KR960703576A (ko) | 고농축 아세트아미노펜 용액을 함유하는 젤라틴 캡슐(gelatin capsules containing a highly concentrated acetaminophen solution) | |
| CA2633924A1 (en) | Gastric reflux resistant dosage forms | |
| EP1163901A4 (en) | SOFT CHEWABLE CAPSULES HAVING IMPROVED ADMINISTRATION PROPERTIES AND PROCESS FOR PRODUCING THE SAME | |
| CN102204874B (zh) | 含天然药物复配成分的抗口臭牙膏 | |
| CN109908103B (zh) | 一种用于制备植物软胶囊的组合物 | |
| RU2013151669A (ru) | Улучшенная устойчивость пероксида в композициях для ухода за полостью рта | |
| CO5840249A1 (es) | Composiciones lubricantes personales y equipos para proveer lubricacion personal | |
| CN109562184B (zh) | 硬度改善的硬胶囊及其制造方法 | |
| MXPA05008033A (es) | Composiciones de milnacipran en forma de multiparticulas para administracion oral. | |
| PE20001414A1 (es) | Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad | |
| EP4674410A3 (en) | Delayed release softgel capsules in higher ph environment | |
| NZ799086A (en) | Controlled release fill compositions and capsules containing same | |
| CA1250526A (en) | Hot melt antihistamine formulations | |
| CN102240277B (zh) | 一种治疗牙周炎的药物组合物及其制备方法及应用 | |
| CN100375617C (zh) | 一种液体胶囊及其制备方法 | |
| JPS5931711A (ja) | 酸単離ゼラチンにより被包したｐｇｅ型組成物 | |
| KR20190093201A (ko) | 겔화 보조제의 석출이 개선된 경질 캡슐 및 그 조제 방법 | |
| JPS61100516A (ja) | ゼラチンカプセル内に封入された練り歯磨 | |
| MXPA06012738A (es) | Composiciones farmaceuticas encapsuladas en gel blando que comprenden ingredientes activos concentrados. |